NUVISAN GMBH
Nuvisan Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. We deliver services ranging from a single test to fully integrated drug development programs.
NUVISAN GMBH
Industry:
Medical Pharmaceutical Therapeutics
Founded:
1979-01-01
Address:
Neu-ulm, Bayern, Germany
Country:
Germany
Website Url:
http://www.nuvisan.com
Total Employee:
1+
Status:
Active
Contact:
+511 437 3652
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-06-01 | Essex Pharma Development | Essex Pharma Development acquired by NUVISAN GmbH | N/A |
Official Site Inspections
http://www.nuvisan.com Semrush global rank: 9.51 M Semrush visits lastest month: 144
- Host name: 13.107.246.41
- IP address: 13.107.246.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NUVISAN GmbH"
CRO/CDMO from Early Discovery to Phase II - NUVISAN
NUVISAN, a European-based CRO/CDMO, provides tailored and high-quality solutions across the drug discovery and development continuum. Explore our services, from Target ID and Validation to Clinical support. ... NUVISAN is a …See details»
A Family-Owned CRO Since 1989 - NUVISAN
The History of NUVISAN Founded in 1979 as an independent, family-owned contract research organization (CRO), NUVISAN started with bioanalytical laboratory services and PK/PD …See details»
NUVISAN The Science CRO | LinkedIn
NUVISAN, a formerly independent, family-owned contract research organization (CRO), has grown significantly over the years and has expanded its services and capabilities to meet the changing needs ...See details»
NUVISAN GmbH - Crunchbase Company Profile
Nuvisan Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device …See details»
NUVISAN Events
Nov 15, 2023 The NUVISAN group is a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO) with its headquarters in Neu-Ulm and six sites in …See details»
NUVISAN Insights - Overview, Brochures, Webinars, …
At NUVISAN, our passion is creating safe and effective topical products to improve the lives of millions of patients worldwide. Our team of experts is dedicated to drug discovery, DMPK, chemical and formulation development, …See details»
Nuvisan 2025 Company Profile: Valuation, Investors, Acquisition
Opeartor of a contract research and development and manufacturing organization (CRO/CDMO) company based in Neu-Ulm, Germany. The company specializes in offering fully integrated …See details»
NUVISAN - Products, Competitors, Financials, Employees, …
Mar 25, 2024 NUVISAN is a Contract Research Organization (CRO) specializing in drug discovery and development within the pharmaceutical and biotechnology sectors. The …See details»
NUVISAN Insights - Overview, Brochures, Webinars, …
NUVISAN provides end-to-end solutions, including high throughput screening with a 3 million-compound library, lead optimization, pharmacology, and translational research. ... NUVISAN is a fully integrated Contract Research Organization …See details»
Clinical Development Services | Drug …
With more than 40 years’ experience as a clinical research organization, NUVISAN offers the full range of solutions for Early Stage clinical drug development, which includes first-in …See details»
Nuvisan Company Profile - Office Locations, Competitors ... - Craft
Nuvisan is a contract research organization performing drug trials for pharmaceutical companies, biotech, and generic manufacturers. The company offers a range of clinical drug development …See details»
ALS to take full ownership and control of Nuvisan
Mar 25, 2024 ALS Limited (ASX: ALQ) has agreed with Nuvisan Pharma Holding GmbH (Nuvisan), to acquire the remaining 51% interest in Nuvisan (which includes Nuvisan GmbH …See details»
Nuvisan Pharma Service - Clinical Trials Arena
Nuvisan Pharma Service is a contract research organisation with decades of experience in pharmacological and pharmacokinetic studies, delivering a comprehensive range of solutions …See details»
Expertise in Clinical Development for Your Drug Candidate
Founded in Europe, NUVISAN is a fully integrated Contract Research Organization with a 40-year track record of serving clients’ needs in early and clinical development for pharmaceutical and …See details»
NUVISAN The Science CRO - Leadership Team - The Org
The Leadership Team at NUVISAN The Science CRO is comprised of senior executives and principal scientists who steer the company's strategic direction, operational excellence, and …See details»
ALS to take full ownership and control of Nuvisan - alsglobal.com
Mar 25, 2024 ALS Limited (ASX: ALQ) has agreed with Nuvisan Pharma Holding GmbH (Nuvisan), to acquire the remaining 51% interest in Nuvisan (which includes Nuvisan GmbH …See details»
NUVISAN Insights - Overview, Brochures, Webinars, Scientific ...
Browse through our pool of scientific publications, videos, webinar recordings, and more to gain a better insight into NUVISAN’s solutions and scientific projects. Discover how our drug …See details»
Informed with NUVISAN News and Updates - NUVISAN
The NUVISAN group, a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO), and ALS Limited, a global company in the testing, inspection and …See details»
Seamless Communication: Submit Your Contact Request Today
Founded in Europe, NUVISAN is a fully integrated Contract Research Organization with a 40-year track record of serving clients’ needs in early and clinical development for pharmaceutical and …See details»
Nuvve outlines strategic shift to stationary battery business amid ...
Ted Smith, COO and President, was assigned to lead efforts in New Mexico as CEO of a local organization managing a $400M electrification project. This includes vehicle-to-grid …See details»